ACXP
ACXP
NASDAQ · Biotechnology

Acurx Pharmaceuticals Inc

$3.52
+0.02 (+0.57%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +460.2% upside
Low Target $18.07
Average Target $19.72
High Target $32.84
Current Price $3.52
Current
$3.52
Target
$19.72
$18.07 $19.72 avg $32.84
Scenario Analysis
Bear Case
$18.07
413.4%
Low target
Base Case
$19.72
+460.2%
Avg target
Bull Case
$32.84
+833.0%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$21.00
-83.2% from high
52-Week Low
$1.33
+165.5% from low
Target vs 52W High
$19.72
-6.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +18.4%
AMGN
Amgen Inc
Hold 42 50% $190.87 -45.8%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +160.2%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -1.8%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.1%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -28.5%